Actively Recruiting
Tumor Control, Treatment Toxicity, Quality of Life and Bio-Imaging Repository Databank (TQ-BIRD) for Cancer Patients
Led by Fengming Kong · Updated on 2026-01-27
5000
Participants Needed
1
Research Sites
548 weeks
Total Duration
On this page
Sponsors
F
Fengming Kong
Lead Sponsor
Q
Queen Mary Hospital, Hong Kong
Collaborating Sponsor
AI-Summary
What this Trial Is About
Our central hypothesis is that patient response to treatment, evaluated by full spectrum of outcome measures including tumor control, survival, toxicity, and quality of life (QoL), will correlate with biomarker expressions, which can be tested in the blood, other body fluid, imaging as well as tumor tissue (if available).
CONDITIONS
Official Title
Tumor Control, Treatment Toxicity, Quality of Life and Bio-Imaging Repository Databank (TQ-BIRD) for Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cancer patients aged 18 years and older.
- Scheduled to receive any kind of therapy at the study center.
- Performance status of ECOG 0, 1, 2, or 3.
- Able to understand quality of life questionnaires.
- Healthy volunteers aged 18 years and older without active cancer (except cured skin cancer).
- Healthy volunteers with ECOG performance status 0, 1, 2, or 3.
You will not qualify if you...
- Participants who are likely unable to complete the study's survey questionnaires.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UHongKongShenzhen
Shenzhen, Guangdong, China
Actively Recruiting
Research Team
L
Li YANG, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here